James Mock
Fortuna: 3 M $ al 31/05/2026
Fortuna: 3 M $ al 31/05/2026
James M. Mock es director financiero y vicepresidente senior de PerkinElmer, Inc. (Estados Unidos). Anteriormente fue vicepresidente de General Electric Co. y director financiero y vicepresidente de GE Oil & Gas, Inc. (una filial de General Electric Co.). Se licenció en la Universidad de St. Lawrence.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MODERNA, INC. 0,02 % | 05/06/2026 | 65.687 ( 0,02 % ) | 3 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MODERNA, INC. | Director Financiero/CFO | 06/09/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| REVVITY, INC. | Director Financiero/CFO | 05/09/2022 |
| GE AEROSPACE | Corporate Officer/Principal | 01/04/2018 |
Baker Hughes Energy Services LLC
Baker Hughes Energy Services LLC Industrial MachineryProducer Manufacturing Manufactures and supplies blower and compressor technologies | Director Financiero/CFO | 01/01/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
GE Aerospace
GE Aerospace Aerospace & DefenseElectronic Technology Designs, develops, manufactures and services aircraft engines for commercial airframes & defense jet engines, avionics & power systems | Electronic Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
St. Lawrence University
St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baker Hughes Energy Services LLC
Baker Hughes Energy Services LLC Industrial MachineryProducer Manufacturing Manufactures and supplies blower and compressor technologies | Producer Manufacturing |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.